Compare DIOD & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DIOD | KNSA |
|---|---|---|
| Founded | 1959 | 2015 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.6B |
| IPO Year | N/A | 2018 |
| Metric | DIOD | KNSA |
|---|---|---|
| Price | $59.47 | $43.66 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 6 |
| Target Price | ★ $58.00 | $52.33 |
| AVG Volume (30 Days) | 300.5K | ★ 671.0K |
| Earning Date | 02-10-2026 | 02-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 4.48 | N/A |
| EPS | ★ 1.38 | 0.47 |
| Revenue | ★ $1,429,793,000.00 | $597,973,000.00 |
| Revenue This Year | $14.41 | $62.70 |
| Revenue Next Year | $8.07 | $31.18 |
| P/E Ratio | ★ $42.30 | $96.31 |
| Revenue Growth | 10.45 | ★ 55.68 |
| 52 Week Low | $32.93 | $18.12 |
| 52 Week High | $61.36 | $45.50 |
| Indicator | DIOD | KNSA |
|---|---|---|
| Relative Strength Index (RSI) | 60.87 | 54.82 |
| Support Level | $57.11 | $42.99 |
| Resistance Level | $61.32 | $45.50 |
| Average True Range (ATR) | 2.41 | 1.69 |
| MACD | 0.02 | 0.28 |
| Stochastic Oscillator | 69.75 | 77.18 |
Diodes Inc is a manufacturer and supplier of high-quality application-specific products within the broad discrete, logic, analog, and mixed-signal semiconductor markets. It serves the customer electronics, computing, communications, industrial, and automotive markets. The Company's products include diodes; rectifiers; transistors; MOSFETs; GPP bridges; GPP rectifiers; protection devices; function-specific arrays; single gate logic; amplifiers and comparators; Hall-effect and temperature sensors; and power management devices, including LED drivers, AC-DC converters and controllers, DC-DC switching and linear voltage regulators, voltage references along with special-function devices, such as USB power switches, load switches, voltage supervisors, and motor controllers.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.